Phase Ib trial of ubidecarenone (BPM 31510) in patients with solid tumours stratified by phenotype
Latest Information Update: 21 Mar 2023
At a glance
- Drugs Ubidecarenone (Primary)
- Indications Brain cancer; Breast cancer; Liver cancer; Pancreatic cancer; Solid tumours
- Focus Therapeutic Use
- 08 Feb 2023 According to a BPG Bio media release, Berg Pharma has been acquired by BPG Bio.
- 27 Nov 2013 New trial record
- 21 Nov 2013 300-400 patients are expected to be enrolled, according to a Berg media release.